WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004098633) COMPOSITION COMPRISING A PDE-4 INHIBITOR AND A TNF ALPHA ANTAGONIST
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/098633    International Application No.:    PCT/EP2004/050748
Publication Date: 18.11.2004 International Filing Date: 10.05.2004
Chapter 2 Demand Filed:    18.11.2004    
IPC:
A61K 38/17 (2006.01), A61K 45/06 (2006.01)
Applicants: ALTANA PHARMA AG [DE/DE]; Byk-Gulden-Str. 2, 78467 Konstanz (DE) (For All Designated States Except US).
BARSIG, Johannes [DE/DE]; (DE) (For US Only).
WEIMAR, Christian [DE/DE]; (DE) (For US Only)
Inventors: BARSIG, Johannes; (DE).
WEIMAR, Christian; (DE)
Agent: WILD, Robert; c/o ALTANA Pharma AG, 78467 Konstanz (DE)
Priority Data:
03010581.1 12.05.2003 EP
Title (EN) COMPOSITION COMPRISING A PDE-4 INHIBITOR AND A TNF ALPHA ANTAGONIST
(FR) COMPOSITION COMPRENANT UN INHIBITEUR DE LA PDE-4 ET UN ANTAGONISTE DU TNF-ALPHA
Abstract: front page image
(EN)The invention relates to the combined administration of a PDE4 inhibitor and a TNF&agr; antagonist selected from the group consisting of etanercept, onercept and pegsunercept for the treatment of a disease in which phosphodiesterase 4 (PDE4) and/or tumor necrosis factor alpha (TNF&agr;) activity is detrimental.
(FR)L'invention concerne l'administration combinée d'un inhibiteur de la PDE4 et d'un antagoniste du TNFa sélectionné dans le groupe renfermant l'étanercept, l'onercept et le pegsunercept pour le traitement d'une maladie dans laquelle l'activité de la phosphodiestérase 4 (PDE4) et/ou du facteur de nécrose tumorale alpha (TNFa) est néfaste.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)